EA202190465A3 - NEW PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN NHL IMMUNOTHERAPY AND OTHER CANCER - Google Patents
NEW PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN NHL IMMUNOTHERAPY AND OTHER CANCERInfo
- Publication number
- EA202190465A3 EA202190465A3 EA202190465A EA202190465A EA202190465A3 EA 202190465 A3 EA202190465 A3 EA 202190465A3 EA 202190465 A EA202190465 A EA 202190465A EA 202190465 A EA202190465 A EA 202190465A EA 202190465 A3 EA202190465 A3 EA 202190465A3
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- peptides
- present
- tumor
- immunotherapy
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Настоящее изобретение относится к пептидам, белкам, нуклеиновым кислотам и клеткам для применения в иммунотерапевтических методах. В частности, настоящее изобретение относится к иммунотерапии рака. Настоящее изобретение относится далее к опухолеассоциированным пептидным эпитопам Т-клеток, в отдельности или в комбинации с другими опухолеассоциированными пептидами, которые могут, например, служить в качестве активных фармацевтических ингредиентов вакцинных композиций, стимулирующих противоопухолевые иммунные ответы, или стимулировать Т-клетки ex vivo с их перенесением в организм пациента. Пептиды, связанные с молекулами главного комплекса гистосовместимости (MHC), или пептиды в отдельности могут быть также мишенями антител, растворимых Т-клеточных рецепторов и других связывающих молекул.The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to tumor-associated T cell peptide epitopes, alone or in combination with other tumor-associated peptides, which can, for example, serve as active pharmaceutical ingredients in vaccine compositions that stimulate anti-tumor immune responses or stimulate T cells ex vivo with their transfer to the patient's body. Peptides associated with major histocompatibility complex (MHC) molecules, or peptides alone, may also be targets for antibodies, soluble T-cell receptors, and other binding molecules.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662297495P | 2016-02-19 | 2016-02-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA202190465A2 EA202190465A2 (en) | 2021-06-30 |
| EA202190465A3 true EA202190465A3 (en) | 2022-01-31 |
Family
ID=62596942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202190465A EA202190465A3 (en) | 2016-02-19 | 2017-02-17 | NEW PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN NHL IMMUNOTHERAPY AND OTHER CANCER |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR107663A1 (en) |
| EA (1) | EA202190465A3 (en) |
-
2017
- 2017-02-17 EA EA202190465A patent/EA202190465A3/en unknown
- 2017-02-17 AR ARP170100409A patent/AR107663A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR107663A1 (en) | 2018-05-23 |
| EA202190465A2 (en) | 2021-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202191027A3 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF SEVERAL TYPES OF TUMORS | |
| EA201992664A3 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF OVARIAN CANCER AND OTHER TYPES OF CANCER | |
| EA201891638A1 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN NHL IMMUNOTHERAPY AND OTHER CANCER TYPES | |
| EA201891116A1 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE USE OF SEVERAL CANCER TYPES IN IMMUNOTHERAPY | |
| EA201891994A1 (en) | Uterus Cancer Treatment | |
| EA201891701A1 (en) | PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE APPLICATION IN IMMUNOTHERAPY OF NON-SMALL CELL LUNG AND OTHER CANCER | |
| EA202091754A1 (en) | PEPTIDES AND COMBINATIONS OF PEPTIDES OF NON-CANONIC ORIGIN FOR USE IN IMMUNOTHERAPY OF DIFFERENT TYPES OF CANCER | |
| EA201892159A1 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE USE OF AML AND OTHER CANCER IN IMMUNOTHERAPY | |
| EA202190186A1 (en) | PEPTIDES, COMBINATIONS OF PEPTIDES AND CELL-BASED MEDICINES FOR USE IN IMMUNOTHERAPY OF BLADDER CANCER AND OTHER TYPES OF CANCER | |
| EA202191120A3 (en) | PEPTIDES AND THEIR COMBINATIONS FOR USE IN CANCER IMMUNOTHERAPY | |
| EA202190465A3 (en) | NEW PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN NHL IMMUNOTHERAPY AND OTHER CANCER | |
| EA202091988A1 (en) | PEPTIDES FOR USE IN IMMUNOTHERAPY OF CANCER | |
| EA202190357A3 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF SEVERAL TYPES OF CANCER | |
| EA202190241A1 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF CLL AND OTHER TYPES OF CANCER | |
| EA202190898A2 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF PANCREAS CANCER AND OTHER TYPES OF CANCER | |
| EA202191013A2 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR OBTAINING FRAMEWORK FOR USE IN TREATMENT OF PANCREAS CANCER AND OTHER TYPES OF CANCER | |
| EA202092560A3 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER | |
| EA202091863A2 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER | |
| CR20200472A (en) | Novel peptides and combination of peptides for use in immunotherapy against various tumors |